Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. (Nasdaq: HSAQ) is a biomedical innovation company that entered the public markets through its business combination with Health Sciences Acquisitions 2 Corp, a healthcare-focused special purpose acquisition company that completed its IPO in 2021. The SPAC was sponsored by Health Sciences Acquisitions 2 Holdings LLC. Orchestra BioMed operates in the medical device and biomedical technology sector, advancing programs in cardiovascular neuromodulation and drug-eluting bioabsorbable scaffold technology. The company filed an 8-K with the Securities and Exchange Commission on October 28, 2025, continuing its obligations as a reporting public company. Sign up for SpacDesk to access full filing history, sponsor profiles, and real-time SPAC analytics for HSAQ and hundreds of other deals.